# Heparan Sulfate Proteoglycans Biosynthesis and Post Synthesis Mechanisms Combine Few Enzymes and Few Core Proteins to Generate Extensive Structural and Functional Diversity

**Authors:** Thibault Annaval, Rebekka Wild, Yoann Crétinon, Rabia Sadir, Romain R. Vivès, Hugues Lortat-Jacob

PMC · DOI: 10.3390/molecules25184215 · 2020-09-14

## TL;DR

This review explains how a small number of enzymes and proteins create diverse heparan sulfate structures, which are important for many biological functions.

## Contribution

The paper explores how enzyme complexes generate structural diversity in heparan sulfate proteoglycans through biosynthesis and post-synthesis mechanisms.

## Key findings

- Heparan sulfate proteoglycans are modified by a small number of enzymes and core proteins.
- Structural diversity arises from both biosynthesis and post-synthesis processes.
- Enzyme complexes may organize in different ways to produce varied oligosaccharide sequences.

## Abstract

Glycosylation is a common and widespread post-translational modification that affects a large majority of proteins. Of these, a small minority, about 20, are specifically modified by the addition of heparan sulfate, a linear polysaccharide from the glycosaminoglycan family. The resulting molecules, heparan sulfate proteoglycans, nevertheless play a fundamental role in most biological functions by interacting with a myriad of proteins. This large functional repertoire stems from the ubiquitous presence of these molecules within the tissue and a tremendous structural variety of the heparan sulfate chains, generated through both biosynthesis and post synthesis mechanisms. The present review focusses on how proteoglycans are “gagosylated” and acquire structural complexity through the concerted action of Golgi-localized biosynthesis enzymes and extracellular modifying enzymes. It examines, in particular, the possibility that these enzymes form complexes of different modes of organization, leading to the synthesis of various oligosaccharide sequences.

## Full-text entities

- **Genes:** Sulf1 (sulfatase 1) [NCBI Gene 240725] {aka MSulf-1, mKIAA1077}, CASK (calcium/calmodulin dependent serine protein kinase) [NCBI Gene 8573] {aka CAGH39, CAMGUK, CMG, FGS4, LIN2, MICPCH}, HS3ST1 (heparan sulfate-glucosamine 3-sulfotransferase 1) [NCBI Gene 9957] {aka 3OST, 3OST1}, HGF (hepatocyte growth factor) [NCBI Gene 3082] {aka DFNB39, F-TCF, HGFB, HPTA, SF}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}, FAM20B (FAM20B glycosaminoglycan xylosylkinase) [NCBI Gene 9917] {aka gxk1}, HPSE (heparanase) [NCBI Gene 10855] {aka HPA, HPA1, HPR1, HPSE1, HSE1}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, CS (citrate synthase) [NCBI Gene 1431], SDC3 (syndecan 3) [NCBI Gene 9672] {aka SDCN, SYND3}, hs2st1a (heparan sulfate 2-O-sulfotransferase 1a) [NCBI Gene 791188] {aka 2-OST, 2OST, HS2st, hs2st1, im:7147474, zgc:158230}, GNS (glucosamine (N-acetyl)-6-sulfatase) [NCBI Gene 2799] {aka G6S}, B4GALT7 (beta-1,4-galactosyltransferase 7) [NCBI Gene 11285] {aka EDSP1, EDSSLA, EDSSPD1, XGALT1, XGPT, XGPT1}, CS-E [NCBI Gene 1433], FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, EXTL3 (exostosin like glycosyltransferase 3) [NCBI Gene 2137] {aka BOTV, EXTL1L, EXTR1, ISDNA, REGR, RPR}, UST (uronyl 2-sulfotransferase) [NCBI Gene 10090] {aka 2OST, CS-2OST}, Spock1 (sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1) [NCBI Gene 20745] {aka Spock, Ticn1, testican}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, B3GALT6 (beta-1,3-galactosyltransferase 6) [NCBI Gene 126792] {aka ALGAZ, EDSP2, EDSSPD2, SEMDJL1, beta3GalT6}, Gzmb (granzyme B) [NCBI Gene 14939] {aka CCP-1/C11, CCP1, Ctla-1, Ctla1, GZB}, GPC5 (glypican 5) [NCBI Gene 2262], SDCBP (syndecan binding protein) [NCBI Gene 6386] {aka MDA-9, MDA9, SDCBP1, ST1, SYCL, TACIP18}, HBEGF (heparin binding EGF like growth factor) [NCBI Gene 1839] {aka DTR, DTS, DTSF, HEGFL}, HS3ST2 (heparan sulfate-glucosamine 3-sulfotransferase 2) [NCBI Gene 9956] {aka 30ST2, 3OST2}, ITGB1 (integrin subunit beta 1) [NCBI Gene 3688] {aka CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA}, Spock3 (sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3) [NCBI Gene 72902] {aka 2900045C01Rik, mKIAA4039}, AREG (amphiregulin) [NCBI Gene 374] {aka AR, AREGB, CRDGF, SDGF}, EXT2 (exostosin glycosyltransferase 2) [NCBI Gene 2132] {aka SOTV, SSMS}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, SULF2 (sulfatase 2) [NCBI Gene 55959] {aka HSULF-2}, GPC6 (glypican 6) [NCBI Gene 10082] {aka OMIMD1}, SRGN (serglycin) [NCBI Gene 5552] {aka PPG, PRG, PRG1}, PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476] {aka BFIC2, BFIS2, DSPB3, DYT10, EKD1, FICCA}, GPC4 (glypican 4) [NCBI Gene 2239] {aka K-glypican, KPTS}, GDNF (glial cell derived neurotrophic factor) [NCBI Gene 2668] {aka ATF, ATF1, ATF2, HFB1-GDNF, HSCR3}, NDST1 (N-deacetylase and N-sulfotransferase 1) [NCBI Gene 3340] {aka HSST, MRT46, NST1}, sau (sauron) [NCBI Gene 33402] {aka BEST:LD28579, BcDNA:LD10657, CG7085, Dmel\CG7085, GOLPH3, Rotini}, SULT4A1 (sulfotransferase family 4A member 1) [NCBI Gene 25830] {aka BR-STL-1, BRSTL1, DJ388M5.3, NST, SULTX3, hBR-STL-1}, XYLT1 (xylosyltransferase 1) [NCBI Gene 64131] {aka DBQD2, PXYLT1, XT-I, XT1, XTI, XYLTI}, GPC3 (glypican 3) [NCBI Gene 2719] {aka DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB}, FGF1 (fibroblast growth factor 1) [NCBI Gene 2246] {aka AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-1}, SDC4 (syndecan 4) [NCBI Gene 6385] {aka SYND4}, CTTN (cortactin) [NCBI Gene 2017] {aka EMS1}, SDC2 (syndecan 2) [NCBI Gene 6383] {aka CD362, HSPG, HSPG1, SYND2}, ACHE (acetylcholinesterase (Yt blood group)) [NCBI Gene 43] {aka ACEE, ARACHE, N-ACHE, YT}, TGFBR3 (transforming growth factor beta receptor 3) [NCBI Gene 7049] {aka BGCAN, betaglycan}, Sparc (secreted acidic cysteine rich glycoprotein) [NCBI Gene 20692] {aka BM-40, ON}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, SDC1 (syndecan 1) [NCBI Gene 6382] {aka CD138, SDC, SYND1, syndecan}, ARSH (arylsulfatase family member H) [NCBI Gene 347527] {aka sulfatase}, Ndst3 (N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3) [NCBI Gene 83398] {aka 4921531K01Rik, 4930511P15Rik, N-HSST 3, NDST-3}, SERPINC1 (serpin family C member 1) [NCBI Gene 462] {aka AT3, AT3D, ATIII, ATIII-R2, ATIII-T1, ATIII-T2}, GPC1 (glypican 1) [NCBI Gene 2817] {aka glypican}, Sulf2 (sulfatase 2) [NCBI Gene 72043] {aka 2010004N24Rik, MSulf-2, mKIAA1247}, ZHX2 (zinc fingers and homeoboxes 2) [NCBI Gene 22882] {aka AFR1, RAF}, B3GALT4 (beta-1,3-galactosyltransferase 4) [NCBI Gene 8705] {aka BETA3GALT4, GALT2, GALT4}, Ndst2 (N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2) [NCBI Gene 17423] {aka Mndns, NDST-2}, AGRN (agrin) [NCBI Gene 375790] {aka AGRIN, CMS8, CMSPPD}, Hs2st1 (heparan sulfate 2-O-sulfotransferase 1) [NCBI Gene 23908] {aka 2OST, Hs2st, mKIAA0448}
- **Diseases:** amyloid depositions (MESH:D058225), ocular defects (MESH:D005124), renal, lung, skeletal, and neuronal defects (MESH:D008171), abnormal neuromuscular junctions (MESH:D020511), Knobloch syndrome (MESH:C537209), infection (MESH:D007239), Simpson-Golabi-Behmel syndrome (MESH:C537340), neurodegenerative diseases (MESH:D019636), myopathy (MESH:D009135), mental retardation (MESH:D008607), kidney, lung and skeletal defects (MESH:D007674), neonatal death (MESH:D066087), platelet disorders (MESH:D001791), developmental defects (MESH:D000094602), renal ischemia (MESH:D007511), acute lymphoblastic leukemia (MESH:D054198), premature death (MESH:D003643), morphological abnormalities (MESH:D000013), Alzheimer's disease (MESH:D000544), myopia (MESH:D009216), coagulation (MESH:D001778), inflammatory cytokines (MESH:D000080424), non-melanoma skin cancer (MESH:D012878), leukemia (MESH:D007938), Schwartz-Jampel syndrome (MESH:D010009), atherosclerosis (MESH:D050197), Silverman-Handmaker (MESH:C537998), inflammation (MESH:D007249), tumor metastasis (MESH:D009362), CNS developmental delay (MESH:D002493), thrombosis (MESH:D013927), fibrosis (MESH:D005355), cancer (MESH:D009369), genetic disorders (MESH:D030342), viral infection (MESH:D014777), breast cancer (MESH:D001943), hypertriglyceridemia (MESH:D015228), retinal degeneration (MESH:D012162), microcephaly (MESH:D008831), NDST (MESH:C536108)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Pseudomonas aeruginosa (species) [taxon 287], Drosophila melanogaster (fruit fly, species) [taxon 7227], Danio rerio (leopard danio, species) [taxon 7955], Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676], Coturnix coturnix (Common quail, species) [taxon 9091], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC7570499/full.md

---
Source: https://tomesphere.com/paper/PMC7570499